June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Application of eye drops for inhibiting scar formation using BMP-7 with excipients
Author Affiliations & Notes
  • Jin-Wook Jang
    Yonsei Univ., Seoul, Republic of Korea
  • Hansoo Kim
    EYEGENE INC., Seoul, Republic of Korea
  • Chan-Young Cho
    EYEGENE INC., Seoul, Republic of Korea
  • Jinkuk Kim
    B&VIIt Gangnam Balgensesang Opthalmology Clinic, Seoul, Republic of Korea
  • Ju-Woong Jang
    Korea Bone Bank Inc., Seoul, Republic of Korea
  • Young-Sik Kim
    Korea Bone Bank Inc., Seoul, Republic of Korea
  • Ynag-je Cho
    EYEGENE INC., Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Jin-Wook Jang, None; Hansoo Kim, None; Chan-Young Cho, None; Jinkuk Kim, None; Ju-Woong Jang, None; Young-Sik Kim, None; Ynag-je Cho, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3880. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jin-Wook Jang, Hansoo Kim, Chan-Young Cho, Jinkuk Kim, Ju-Woong Jang, Young-Sik Kim, Ynag-je Cho; Application of eye drops for inhibiting scar formation using BMP-7 with excipients. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3880.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: The purpose of this study is to applicate BMP-7 for inhibiting scar formation eye drop with excipients.

Methods: 1. Effect of BMP-7 with excipients in HaCaT cells: The expression levels of TGF-beta induced fibronectin and alpha-SMA in HaCaT cells were measured. HaCaT cells were split 6 well plates. 2 days after, the cells were serum-starved. Then 5 ng/ml of TGF-beta and 200 ng/ml of BMP-7 with excipients (Hyaluronic acid, Chitosan and Cyclodextrin) were treated and incubated for 24 hours. The supernatants were collected, TGF-beta induced fibronectin and alpha-SMA were measured by western blot and ELISA. 2. Cell viability influence of BMP-7 with excipients: Cell viability was measured cell viability assay kit based on colormetric assay. HaCaT cells were cultured in a 96-well plate for 24 hours. Then BMP-7 only and BMP-7 with excipients were treated for 48 hours. After treatments, 10 μl of Kit reagent put into each well and incubated for 1 hour. Finally, optical density of 450 nm was measured by plate reader.

Results: TGF-β induced fibronectin and α-SMA expression is reduced by BMP-7 with Hyaluronic acid, Chitosan and Cyclodextrin in HaCaT cells. The excipients did not interfere with effects of BMP-7 and also did not affect cell viability.

Conclusions: BMP-7 with excipients has the ability to reduce fibrosis and also the excipients contributed to the stabilization of BMP-7. As such, it seems possible that this technology can be applied to eye drops and become a new innovative treatment in pharmaceutical markets.

Keywords: 765 wound healing  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.